Global market: about $580 to $640 billion in 2026

There is no official global figure for medical devices, so market size comes from commercial research firms. Three widely cited estimates broadly agree:

Source20252026ForecastGrowth a year
Statistanot stated$576.9 billion$755.2 billion (2031)5.5%
Fortune Business Insights$572.3 billion$605.0 billion$1.03 trillion (2034)6.9%
MarketsandMarkets (top 10 device categories)$603.5 billion$637.4 billion$829.7 billion (2031)5.4%

Taken together, the global device market is roughly $580 to $640 billion in 2026. It is growing about 5 to 7% a year, which would put it at roughly $750 to $830 billion by 2031.

Regional patterns:

  • North America is about 38% of the market, according to both Fortune Business Insights and MarketsandMarkets.
  • Asia Pacific is expected to grow fastest, according to MarketsandMarkets.

The drug market is about three times larger: IQVIA puts global medicine spending at about $1.74 trillion in 2024.

US market: about $210 billion

The US is the world’s largest device market.

MeasureValueSource
US market, 2026about $210 to $214 billionFortune Business Insights ($210.5B); Statista ($213.8B)
Share of global marketover 40%AdvaMed
Medtech companies in the USover 6,500, mostly with fewer than 100 employeesAdvaMed
Direct US jobsnearly 519,000AdvaMed

The AdvaMed share (over 40%) is higher than the commercial estimates imply (about 37%, our arithmetic from $210 to $214 billion against $577 to $605 billion). The figures likely use different scopes and years.

Growth signals.

  • FDA authorized 5,640 devices in 2025, up from 5,564 in 2024.
  • Original PMA approvals are on track for about 51 in 2026, up from 40 to 41 in 2025.
  • Medtech venture funding reached $8.0 billion in the first nine months of 2026.

Segments and leaders

Largest segments. The sources slice the market differently:

  • Statista: cardiology devices are the largest category, at about $89 billion in 2026.
  • Fortune Business Insights and MarketsandMarkets: in vitro diagnostics (IVD) are the largest type, with a 13.5% and 18.5% share respectively.
  • Fortune Business Insights: hospitals and ambulatory surgery centers buy about 49% of devices.

AI-enabled devices. These are a fast-growing part of the market. FDA authorized 335 of them in 2025, and its list reached 1,614 in total by June 2026. About 75% are in radiology.

Largest companies.

[Chart: Medical Design & Outsourcing, 2026 Medtech Big 100 (latest fiscal year revenue). See the live document for the chart.]

The top 10 companies earn about $250 billion. That is roughly 40% of the global market. Revenue is concentrated in a few diversified groups, while most of the 6,500-plus US medtech companies are small. Medtronic leads with $36.4 billion, and Abbott’s device business moved up from 8th to 6th.

Why market size estimates differ

  • Definition. Some include IVD, dental, and consumables; others count only selected categories. MarketsandMarkets, for example, covers its top 10 categories.
  • Revenue or spending. Company revenue includes sales outside devices and outside any one country.
  • Inconsistent reports. One commercial page gave two different 2025 North America figures ($218 billion and $102 billion). Always check the method before citing a number.
  • No official total. Unlike drugs, where IQVIA tracks invoice and net spending, devices have no single reference series.

Using market data in AI and RAG

  1. Store each figure with its source, definition, and year. Do not merge figures from different firms into one series.
  2. Quote ranges, not single numbers, when sources disagree.
  3. Prefer company filings and FDA data for facts you can verify, and use commercial estimates for context.
  4. Refresh annually, as research firms revise their bases.

Common mistakes

  • Citing one commercial estimate as “the” market size.
  • Comparing a 2031 forecast from one firm with a 2034 forecast from another.
  • Adding company revenues to estimate the market.
  • Using AdvaMed’s share and a commercial dollar total together without noting the scope difference.

Checklist

  • Source, definition, and year recorded for each figure
  • Ranges shown where sources differ
  • Forecast horizons aligned
  • Annual refresh scheduled

How AskDona helps

AskDona checks the market figures in your business plans, investor decks, and market access documents against the reports you load. It shows which source and definition each number comes from, and flags figures that are mixed or have no source.

Run a sample market-size evidence check

AskDona shows the evidence; your strategy and finance teams decide.

Editor’s note. This article is general information, not investment advice. Global and US market figures are commercial estimates from Statista, Fortune Business Insights, and MarketsandMarkets, which use different definitions. Company revenue comes from Medical Design & Outsourcing’s Medtech Big 100.

FAQ

How big is the global medical device market? About $580 to $640 billion in 2026, depending on the source.

How fast is it growing? About 5 to 7% a year, which points to roughly $750 to $830 billion by 2031.

How big is the US market? About $210 to $214 billion in 2026. It is the largest single country market.

Who are the largest device companies? Medtronic ($36.4 billion), Johnson & Johnson MedTech ($33.8 billion), and Medline ($28.4 billion).

References

All pages opened and checked by October 30, 2026.

SourceWhat it supports
Statista: Medical Devices, Worldwide$576.9B (2026), 2031 forecast, US $213.8B, cardiology
Fortune Business Insights: Medical devices market2025 and 2026 size, 2034 forecast, US $210.5B, segments
MarketsandMarkets: Top 10 medical devices market2025 and 2026 size, 2031 forecast, IVD share
AdvaMed: Industry factsOver 40% US share, 6,500 companies, jobs
Medical Design & Outsourcing: 2026 Medtech Big 100Top 10 company revenue
Emergo by UL: CDRH 2025 annual report5,640 authorizations
IntuitionLabs: FDA AI-enabled device listAI device counts
J.P. Morgan: Q3 2026 deal reports$8.0B medtech venture funding
IQVIA: Global Use of Medicines 2025 (PDF)Drug market comparison